Rotigotine Transdermal System Improves Neuropsychiatric Features (Apathy, Anhedonia, Anxiety, and Depression) and Fatigue in Patients with Parkinson's Disease: A Post-Hoc Analysis of Five Double-Blind Placebo-Controlled Studies (P06.088)

Efficacy and safety of rotigotine in elderly patients with Parkinson’s disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials

Journal of Neurology ◽

10.1007/s00415-017-8671-0 ◽

2017 ◽

Vol 265 (2) ◽

pp. 253-265 ◽

Cited By ~ 9

Author(s):

Masahiro Nomoto ◽

Hirotaka Iwaki ◽

Hiroyuki Kondo ◽

Masaya Sakurai

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Elderly Patients ◽

Controlled Trials ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Correction to: Efficacy and safety of rotigotine in elderly patients with Parkinson’s disease in comparison with the non-elderly: a post hoc analysis of randomized, double-blind, placebo-controlled trials

Journal of Neurology ◽

10.1007/s00415-017-8706-6 ◽

2017 ◽

Vol 265 (2) ◽

pp. 266-272

Author(s):

Masahiro Nomoto ◽

Hirotaka Iwaki ◽

Hiroyuki Kondo ◽

Masaya Sakurai

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Elderly Patients ◽

Controlled Trials ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Post Hoc Analysis ◽

Incidence of treatment-emergent adverse events in Parkinson's Disease patients according to baseline body mass index: Post-hoc analysis from double-blind combined BIPARK-I and II data

10.1016/j.jns.2019.10.1167 ◽

2019 ◽

Vol 405 ◽

pp. 200

Author(s):

R. Costa ◽

J. Ferreira ◽

A. Lees ◽

E. Tolosa ◽

W. Poewe ◽

...

Keyword(s):

Parkinson’S Disease ◽

Body Mass Index ◽

Parkinson's Disease ◽

Adverse Events ◽

Body Mass ◽

Baseline Body Mass Index ◽

Double Blind ◽

Post Hoc Analysis ◽

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline disease severity: Post-hoc analysis from double-blind combined BIPARK-I and II data

10.1016/j.jns.2019.10.1170 ◽

2019 ◽

Vol 405 ◽

pp. 201-202

Author(s):

R. Costa ◽

A. Lees ◽

J. Ferreira ◽

O. Rascol ◽

F. Stocchi ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Disease Severity ◽

Double Blind ◽

Post Hoc Analysis ◽

Post Hoc ◽

Baseline Disease Severity

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline dopamine agonist use: Post-hoc analysis from double-blind combined BIPARK-I and II data

10.1016/j.jns.2019.10.1168 ◽

2019 ◽

Vol 405 ◽

pp. 200-201

Author(s):

R. Costa ◽

A. Lees ◽

J. Ferreira ◽

O. Rascol ◽

F. Stocchi ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Dopamine Agonist ◽

Double Blind ◽

Post Hoc Analysis ◽

Rotigotine Transdermal System Improves Pain in Patients with Parkinson's Disease: A Post-Hoc Analysis of Patients Reporting Pain in the RECOVER Study (P06.085)

Neurology ◽

10.1212/wnl.78.1_meetingabstracts.p06.085 ◽

2012 ◽

Vol 78 (Meeting Abstracts 1) ◽

pp. P06.085-P06.085

Author(s):

T. Zesiewicz ◽

O. Rascol ◽

J. Friedman ◽

E. Surmann ◽

B. Boroojerdi ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Post Hoc Analysis ◽

Rotigotine Transdermal System ◽

0997 Rotigotine transdermal system as adjunctive therapy to levodopa in patients with advanced-stage Parkinson's disease. Results of a randomized, double-blind, placebo-controlled, multicenter, multinational trial

10.1016/s0022-510x(05)81362-0 ◽

2005 ◽

Vol 238 ◽

pp. S353

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adjunctive Therapy ◽

Advanced Stage ◽

Double Blind ◽

Double Blind Placebo ◽

Multinational Trial ◽

Rotigotine Transdermal System

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to gender: Post-hoc analysis from double-blind combined BIPARK-I and II data

10.1016/j.jns.2019.10.1169 ◽

2019 ◽

Vol 405 ◽

pp. 201

Author(s):

R. Costa ◽

J. Ferreira ◽

A. Lees ◽

E. Tolosa ◽

W. Poewe ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Double Blind ◽

Post Hoc Analysis ◽

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to race: Post-hoc analysis from double-blind combined BIPARK-I and II data

10.1016/j.jns.2019.10.1172 ◽

2019 ◽

Vol 405 ◽

pp. 202-203

Author(s):

R. Costa ◽

A. Lees ◽

J. Ferreira ◽

O. Rascol ◽

F. Stocchi ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Double Blind ◽

Post Hoc Analysis ◽

Incidence of treatment-emergent adverse events in Parkinson's disease patients according to baseline mao-b inhibitors use: Post-hoc analysis from double-blind combined BIPARK-I and II data

10.1016/j.jns.2019.10.1171 ◽

2019 ◽

Vol 405 ◽

pp. 202

Author(s):

R. Costa ◽

J. Ferreira ◽

A. Lees ◽

E. Tolosa ◽

W. Poewe ◽

...

Keyword(s):

Parkinson’S Disease ◽

Parkinson's Disease ◽

Adverse Events ◽

Double Blind ◽

Mao B ◽

Post Hoc Analysis ◽